Related Vendors
Pharmaceutical Market grows in Emerging Countries
High volume business has become a domain of specialized generic drug manufacturers. In the USA, the world’s most important drug market, already two third of all prescriptions dispensed are for generic drugs – a trend the VDMA expects to continue.
Especially this high volume business aims for reducing unit costs with the regard to new investments putting the focus on OEE (overall equipment efficiency). Manufactures of standard drugs compete with production in threshold countries like China or India while the requirements in production and packaging technology are increasing.
Market researcher IMS-health predicts that emerging countries – namely China, India, Brazil, Russia and 13 further states, called the “Pharmerging” countries by IMS – are contributing more than half of the recent worldwide growth in the demand for drugs.
The VDMA expects this to be chance for the technological expertise of German producers of pharmaceutical machinery despite price-aggressive regional competition. “In the order books of our members the importance of the “Pharmerging” countries (..) can be retraced clearly. Our sector reacts with the extension of service capacities and construction of assembly and production capacities in growth regions,” commented Golz.
Recent statistics show a reduction of the Western European and North American sales share from two third to about half of the global market volume during the last five years.
(ID:27329110)